New Study Finds RSV Shots Linked to Higher Risk of Guillain-Barre Syndrome

Saturday, 2 March 2024, 13:48

A recent study reveals that the new RSV vaccines by GSK and Pfizer have been associated with a slight increase in the risk of Guillain-Barre syndrome, a rare neurological disorder. This finding raises concerns about the safety of these vaccines in certain populations. It is crucial for healthcare providers and patients to be aware of this potential risk when considering RSV vaccination options.

https://store.livarava.com/4ce38084-d89d-11ee-b8b8-5254a2021b2b.jpe — New Study Finds RSV Shots Linked to Higher Risk of Guillain-Barre Syndrome

RSV Vaccine Side Effects

A recent study has shown that the newly introduced RSV vaccines manufactured by GSK and Pfizer may have unintended consequences.

Increased Risk of Neurological Disorder

The study indicates a slight rise in the risk of Guillain-Barre syndrome, a rare but serious nervous system condition.

Important: Healthcare providers need to assess the risks and benefits of these vaccines carefully.
Caution: Patients should be informed about this potential side effect before opting for the RSV vaccination.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

RSV Vaccine Side Effects

Increased Risk of Neurological Disorder

Related posts